|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2006-12-4
|
|
pubmed:abstractText |
The burden of diabetes mellitus type 2 (DM2) is increasing worldwide. The combination of DM2 and hypertension (HT) is frequently encountered. Concurrent use of drugs blocking the renin angiotensin system (angiotensin-converting enzyme inhibitor (ACEI), angiotensin receptor blocker (ARB)) and metformin have become frequent in this group of patients. That combination can become life-threatening under certain circumstances.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0301-0430
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
66
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
380-5
|
|
pubmed:meshHeading |
pubmed-meshheading:17140168-Acidosis, Lactic,
pubmed-meshheading:17140168-Aged,
pubmed-meshheading:17140168-Aged, 80 and over,
pubmed-meshheading:17140168-Angiotensin II Type 1 Receptor Blockers,
pubmed-meshheading:17140168-Angiotensin-Converting Enzyme Inhibitors,
pubmed-meshheading:17140168-Antihypertensive Agents,
pubmed-meshheading:17140168-Diabetes Mellitus, Type 2,
pubmed-meshheading:17140168-Drug Therapy, Combination,
pubmed-meshheading:17140168-Female,
pubmed-meshheading:17140168-Humans,
pubmed-meshheading:17140168-Hypertension,
pubmed-meshheading:17140168-Hypoglycemic Agents,
pubmed-meshheading:17140168-Male,
pubmed-meshheading:17140168-Metformin,
pubmed-meshheading:17140168-Middle Aged,
pubmed-meshheading:17140168-Renin-Angiotensin System
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Metformin and antihypertensive therapy with drugs blocking the renin angiotensin system, a cause of concern?
|
|
pubmed:affiliation |
Department of Nephrology, Ulleval University Hospital, Oslo, Norway. helga.gudmundsdottir@ulleval.no
|
|
pubmed:publicationType |
Journal Article,
Case Reports
|
